Published date: 9 February 2021

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 16 April 2020, 12pm

Contract summary

Industry

  • Peptones and protein substances - 24956000

Location of contract

South West

Value of contract

£26,523

Procurement reference

tender_238185/924262

Published date

9 February 2021

Closing date

16 April 2020

Closing time

12pm

Contract start date

17 April 2020

Contract end date

16 April 2021

Contract type

Supply contract

Procedure type

Single tender action (below threshold)

A direct contract with a single supplier, without competition.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

This requirement was to develop a rapid and effective therapy against infection by developing an ovine immunoglobulin treatment against the spike protein of Covid 19.

More information

Additional text

PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the COVID -19 outbreak for the research of therapeutic antibodies.

Award information

Awarded date

17 February 2021

Contract start date

17 April 2020

Contract end date

16 April 2021

Total value of contract

£26,523

This contract was awarded to 1 supplier.

The Native Antigen Company

Address

Langford Lane, Kidlington ,Oxford, Oxfordshire ,OX5 ,1LH UK

Reference

No reference - other

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Address

61 Colindale Avenue, London, NW9 5EQ
London
NW9 5EQ
England

Email

imran.rahman@phe.gov.uk